Fibrinogen and fibrinolytic pathway components

Fibrinogen is a soluble 340 kDa hexameric glycoprotein synthesized in the liver that serves as the essential precursor to fibrin, the primary structural component of blood clots [2, 6, 13]. Upon vascular injury, the enzyme thrombin cleaves fibrinopeptides from fibrinogen, triggering its polymerization into an insoluble fibrin mesh that stabilizes the platelet plug and ensures hemostasis [3, 12, 14]. The fibrinolytic pathway is the physiological system responsible for the controlled dissolution of these clots to maintain vascular patency and prevent permanent occlusion [1, 5, 9]. This process is primarily mediated by plasmin, a serine protease generated from its zymogen plasminogen by activators such as tissue plasminogen activator (tPA) and urokinase (uPA) [5, 11, 15]. Dysregulation of this delicate balance between fibrin formation and degradation is central to the pathogenesis of various conditions, including myocardial infarction, ischemic stroke, and venous thromboembolism, as well as bleeding disorders like afibrinogenemia [1, 3, 8, 12]. Therapeutic strategies targeting this system include thrombolytic agents (e.g., alteplase) that activate plasminogen to dissolve life-threatening clots, and antifibrinolytics (e.g., tranexamic acid) that inhibit fibrinolysis to manage severe hemorrhage [5, 8, 12].

Other names

Coagulation Factor I [3]Fibrinogen [2]Fibrin [2]Plasminogen-plasmin system [1]Fibrinolysis system [1, 4]

Thrombolytic drugs (e.g., alteplase) act as plasminogen activators, converting plasminogen to plasmin on the fibrin surface to dissolve clots [5, 9]. Antifibrinolytic drugs (e.g., tranexamic acid) competitively inhibit the binding of plasminogen and plasmin to fibrin by occupying lysine-binding sites, thereby preventing clot degradation [5, 12]. Fibrinogen concentrates provide substrate for clot formation in deficiency states [12], while defibrinogenating agents (e.g., ancrod) deplete systemic fibrinogen by producing unstable fibrin that is rapidly cleared [6].